Aspen Pharmacare Share Holder Equity 2017-2025 | APNHY
Aspen Pharmacare share holder equity from 2017 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
|
Aspen Pharmacare Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $4,678 |
| 2024 | $4,540 |
| 2023 | $4,864 |
| 2022 | $4,668 |
| 2021 | $4,279 |
| 2020 | $4,458 |
| 2019 | $3,822 |
| 2018 | $3,912 |
| 2017 | $3,168 |
| 2016 | $2,950 |
|
Aspen Pharmacare Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-12-31 | $4,735 |
| 2025-06-30 | $4,678 |
| 2024-12-31 | $4,748 |
| 2024-06-30 | $4,540 |
| 2023-12-31 | $4,571 |
| 2023-06-30 | $4,864 |
| 2022-12-31 | $4,272 |
| 2022-06-30 | $4,668 |
| 2021-12-31 | $4,677 |
| 2021-06-30 | $4,279 |
| 2020-12-31 | $4,260 |
| 2020-06-30 | $4,458 |
| 2019-06-30 | $3,822 |
| 2018-12-31 | $3,655 |
| 2018-06-30 | $3,912 |
| 2017-12-31 | $3,256 |
| 2017-06-30 | $3,168 |
| 2016-12-31 | $2,843 |
| 2016-06-30 | $2,950 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $4.248B | $2.065B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $45.423B | 17.88 |
| BridgeBio Pharma (BBIO) | United States | $13.021B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $10.175B | 25.94 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.445B | 20.49 |
| Bausch Health Cos (BHC) | Canada | $2.121B | 1.32 |
| Personalis (PSNL) | United States | $1.717B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.636B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.005B | 9.45 |
| Assembly Biosciences (ASMB) | United States | $0.508B | 24.48 |
| Sol-Gel Technologies (SLGL) | Israel | $0.169B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.042B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |